Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441266 · ClinicalTrials.gov registry record · NA
M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis
A NA study of Radiation Dermatitis, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06441266: Recruiting NA study of Radiation Dermatitis, sponsored by Wake Forest University Health Sciences.
NCT06441266 is a NA study of Radiation Dermatitis that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 16 participants, below the 47-participant average among 5 other Radiation Dermatitis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06441266, a NA study of Radiation Dermatitis, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation therapy.
Primary Outcome
Participants to complete 75% or more of required assessments over the course of the study will be calculated in two steps. First, investigators will separate patients into two groups, those who have completed 75% or more of their scheduled assessments over all time periods, and those who have not. Investigators will then divide the former number by the total number of patients who completed the study (i.e., completed their radiation treatment) with a final anticipated analyzable number of 16, us
Conditions Studied
Interventions
- DRUG KeraStat cream
- DEVICE M-PART Assessments via MyCap
- OTHER Clinical Assessments
- OTHER Feedback phone interview
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT06441266 shows while recruiting
NCT06441266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 47-participant average among 5 other Radiation Dermatitis trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Radiation Dermatitis appearing as the primary indexed condition, and to 4 interventions - of which KeraStat cream is the first listed.
NCT06441266 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06441266 about?
NCT06441266 is a clinical study titled "M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis". The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation therapy.
What is the current status of trial NCT06441266?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-05-08. Estimated completion is 2027-08.
What conditions does trial NCT06441266 study?
This clinical trial studies the following conditions: Radiation Dermatitis.
What interventions are being tested in trial NCT06441266?
The interventions under investigation include: KeraStat cream (DRUG), M-PART Assessments via MyCap (DEVICE), Clinical Assessments (OTHER), Feedback phone interview (OTHER).
Who is sponsoring clinical trial NCT06441266?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06441266 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
RECRUITING · NA
-
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
COMPLETED · NA
-
3M Cavilon Advanced Skin Protectant for the Prophylaxis of Radiation Dermatitis
COMPLETED
-
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
COMPLETED · Phase 3
-
Bacterial Decolonization to Prevent Radiation Dermatitis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI